tirzepatide cardiovascular outcomes trial results july 2025 An Observational Study of of vs Glucagon-Like Peptide-1 Receptor Agonists Effects of tirzepatide on circulatory

A., Ismail, A

Who might benefit more from a pill instead of a shot

By: Mike Montemarano Associate Editor, Nutraceuticals World An ongoing NIH-funded study which will be published in the Annals of Medicine and Surgery Journal, is investigating the outcomes in patients suffering from heart failure with preserved ejection fraction (HFpEF) who are supplementing with a either combination of CoQ10 in the form of ubiquinol and D-ribose, a simple sugar from which RNA is built, only one of the ingredients, or placebo

By the end of the drip, most people are clear-headed and ready to actually move through their day

It also frames medication as an addition to continued lifestyle support rather than a replacement for it

Seattle (WA)